Lemon oil vapor causes an anti-stress effect via modulating the 5-HT and DA activities in mice

被引:160
作者
Komiya, Migiwa
Takeuchi, Takashi [1 ]
Harada, Etsumori
机构
[1] Tottori Univ, Dept Vet Med, Tottori 6808553, Japan
[2] Rakuno Gakuen Univ, Ebetsu, Hokkaido 0698501, Japan
[3] Yamaguchi Univ, Fac Agr, Grad Sch Vet Sci, Yamaguchi 7538515, Japan
关键词
lemon oil; distress; anxiolytic; antidepressant; 5-HT; DA;
D O I
10.1016/j.bbr.2006.05.006
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
We examined the anti-stress action of the essential oils of lavender, rose, and lemon using an elevated plus-maze task (EPM), a forced swimming task (FST), and an open field task (OFT) in mice. Lemon oil had the strongest anti-stress effect in all three behavioral tasks. We further investigated a regulatory mechanism of the lemon oil by pre-treatments with agonists or antagonists to benzodiazepine, 5-HT, DA, and adrenaline receptors by the EPM and the FST. The anti-stress effect of lemon oil was significantly blocked by pre-treatment with frumazenil, benzodiazepine receptor antagonist, or apomorphine, a nonselective DA receptor agonist. In contrast, agonists or antagonists to the 5-HT receptor and the alpha-2 adrenaline receptor did not affect the anti-stress effect of lemon oil. Buspirone, DOI, and mianserine blocked the antidepressant-like effect of lemon oil in the FST, but WAY] 00,635 did not. These findings suggest that the antidepressant-like effect of lemon oil is closely related with the 5-HTnergic pathway, especially via 5-HT1A receptor. Moreover, the lemon oil significantly accelerated the metabolic turnover of DA in the hippocampus and of 5-HT in the prefrontal cortex and striatum. These results suggest that lemon oil possesses anxiolytic, antidepressant-like effects via the suppression of DA activity related to enhanced 5-HTnergic neurons. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:240 / 249
页数:10
相关论文
共 40 条
  • [1] Potentiation of GABAA receptors expressed in Xenopus oocytes by perfume and phytoncid
    Aoshima, H
    Hamamoto, K
    [J]. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1999, 63 (04) : 743 - 748
  • [2] Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism
    Bishop, C
    Tessmer, JL
    Ullrich, T
    Rice, KC
    Walker, PD
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (02) : 687 - 694
  • [3] Alterations in GABAergic function following forced swimming stress
    Briones-Aranda, A
    Rocha, L
    Picazo, O
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2005, 80 (03) : 463 - 470
  • [4] BUCHBAUER G, 1991, Z NATURFORSCH C, V46, P1067
  • [5] FRAGRANCE COMPOUNDS AND ESSENTIAL OILS WITH SEDATIVE EFFECTS UPON INHALATION
    BUCHBAUER, G
    JIROVETZ, L
    JAGER, W
    PLANK, C
    DIETRICH, H
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (06) : 660 - 664
  • [6] Anxiolytic and sedative effects of extracts and essential oil from Citrus aurantium L.
    Carvalho-Freitas, MIR
    Costa, M
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (12) : 1629 - 1633
  • [7] Effects of long-term exposure of lemon essential oil odor on behavioral, hormonal and neuronal parameters in male and female rats
    Ceccarelli, I
    Lariviere, WR
    Fiorenzani, P
    Sacerdote, P
    Aloisi, AM
    [J]. BRAIN RESEARCH, 2004, 1001 (1-2) : 78 - 86
  • [8] Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase
    Chiavegatto, S
    Dawsons, VL
    Mamounas, LA
    Koliatsos, VE
    Dawson, TM
    Nelson, RJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (03) : 1277 - 1281
  • [9] Cooke B, 2000, BRIT J GEN PRACT, V50, P493
  • [10] Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats
    Davids, E
    Zhang, KH
    Kula, NS
    Tarazi, FI
    Baldessarini, RJ
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (03) : 1097 - 1102